vers la météo de la validation par utilisateur
+-----------------OBJ:V-N----------------+ +---------COMP:V-N(in)---------+ | +-------COMP:V-N(In)-------+ +--MOD_ATT:N-N--+ +-MOD_POST:N-ADJ-+ +MOD_A+ +MOD_AT+SUBJ:V-N+ | +MOD_ATT:+ +COMP:N-N+ +----COMP:ADJ-N(from)---+ | | | | | | | | | | | | In HepG2 cells , 17 beta __NODE__ increases ( in a dose dependent manner ) activity of DNA endogenous promoter from __NODE__ gene . MOD_ATT:N-N (cell,HepG2) MOD_ATT:N-N (__NODE__,beta) COMP:V-N(In) (increase,cell) SUBJ:V-N (increase,__NODE__) COMP:V-N(in) (increase,manner) OBJ:V-N (increase,activity) MOD_ATT:N-N (manner,dose) MOD_ATT:N-N (manner,dependent) COMP:N-N(of) (activity,DNA) MOD_POST:N-ADJ (activity,endogenous) COMP:ADJ-N(from) (endogenous,__NODE__)
+-----------------OBJ:V-N----------------+ +---------COMP:V-N(in)---------+ | +-------COMP:V-N(In)-------+ +--MOD_ATT:N-N--+ +-MOD_POST:N-ADJ-+ +MOD_A+ +MOD_AT+SUBJ:V-N+ | +MOD_ATT:+ +COMP:N-N+ +----COMP:ADJ-N(from)---+ | | | | | | | | | | | | In HepG2 cells , 17 beta __NODE__ increases ( in a dose dependent manner ) activity of DNA endogenous promoter from __NODE__ gene . MOD_ATT:N-N (cell,HepG2) MOD_ATT:N-N (__NODE__,beta) COMP:V-N(In) (increase,cell) SUBJ:V-N (increase,__NODE__) COMP:V-N(in) (increase,manner) OBJ:V-N (increase,activity) MOD_ATT:N-N (manner,dose) MOD_ATT:N-ADJ (manner,dependent) COMP:N-N(of) (activity,DNA) MOD_POST:N-ADJ (activity,endogenous) COMP:ADJ-N(from) (endogenous,__NODE__)
+-----------------OBJ:V-N----------------+--------------COMP:N-N(of)--------------+ +---------COMP:V-N(in)---------+ | +----------MOD_ATT:N-N----------+ +-------COMP:V-N(In)-------+ +--MOD_ATT:N-N--+ | | +-----MOD_ATT:N-ADJ-----+ +MOD_A+ +MOD_AT+SUBJ:V-N+ | +MOD_ATT:+ | | | +-MOD_ATT:N-N-+ | | | | | | | | | | | | | In HepG2 cells , 17 beta __NODE__ increases ( in a dose dependent manner ) activity of DNA endogenous promoter from __NODE__ gene . MOD_ATT:N-N (cell,HepG2) MOD_ATT:N-N (__NODE__,beta) COMP:V-N(In) (increase,cell) SUBJ:V-N (increase,__NODE__) COMP:V-N(in) (increase,manner) OBJ:V-N (increase,activity) MOD_ATT:N-N (manner,dose) MOD_ATT:N-N (manner,dependent) COMP:N-N(of) (activity,__NODE__) MOD_ATT:N-N (__NODE__,DNA) MOD_ATT:N-ADJ (__NODE__,endogenous) MOD_ATT:N-N (__NODE__,promoter)
+-----------------OBJ:V-N----------------+--------------COMP:N-N(of)--------------+ +---------COMP:V-N(in)---------+ | +----------MOD_ATT:N-N----------+ +-------COMP:V-N(In)-------+ +--MOD_ATT:N-N--+ | | +-----MOD_ATT:N-ADJ-----+ +MOD_A+ +MOD_AT+SUBJ:V-N+ | +MOD_ATT:+ | | | +-MOD_ATT:N-N-+ | | | | | | | | | | | | | In HepG2 cells , 17 beta __NODE__ increases ( in a dose dependent manner ) activity of DNA endogenous promoter from __NODE__ gene . MOD_ATT:N-N (cell,HepG2) MOD_ATT:N-N (__NODE__,beta) COMP:V-N(In) (increase,cell) SUBJ:V-N (increase,__NODE__) COMP:V-N(in) (increase,manner) OBJ:V-N (increase,activity) MOD_ATT:N-N (manner,dose) MOD_ATT:N-ADJ (manner,dependent) COMP:N-N(of) (activity,__NODE__) MOD_ATT:N-N (__NODE__,DNA) MOD_ATT:N-ADJ (__NODE__,endogenous) MOD_ATT:N-N (__NODE__,promoter)